Luo Zhenkai, Jiao Binbin, Yan Yangxuanyu, Liu Yuhao, Chen Haijie, Guan Yunfan, Ding Zhenshan, Zhang Guan
Graduate School of Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
J Cancer Res Clin Oncol. 2023 Nov;149(15):14241-14253. doi: 10.1007/s00432-023-05237-5. Epub 2023 Aug 9.
We aimed to establish and validate a nomogram for extraurothelial recurrence (EUR) after radical nephroureterectomy (RNU) for upper urinary tract urothelial carcinoma (UTUC).
The data of 521 patients with UTUC after RNU from 2 medical centers were retrospectively studied and were used as training cohort (n = 301) and external validation cohort (n = 220). We used the least absolute shrinkage and selection operator (LASSO) to select variables for multivariable Cox regression, and included independent risk factors into nomogram models predicting EUR-free survival (EURFS). Multiple parameters were used to validate the nomogram, including the concordance index (C-index), the calibration plots, the time-dependent receiver-operator characteristics curve (ROC), and the decision curve analysis (DCA). Patients were stratified into three risk groups according to total points calculated by nomograms. The differences of EURFS in each group were analyzed by the Kaplan-Meier analysis.
Four variables were screened through LASSO regression. Bladder cancer history, Ki-67, lymphovascular invasion (LVI), and pathological T stage were shown to be independent predictive factors for EUR. The C-indexes of the model were 0.793 and 0.793 in training and validation cohorts, respectively. In comparison with prediction based on categorized pathological T stage, the DCA curves for 5-year EUR exhibited better performance. The 5-year EURFS rates were 92.2%, 63.8%, and 36.2% in patients stratified to the low-, medium-, and high-risk group.
Our study provided a new nomogram to predict the probability of EUR in UTUC patients underwent RNU, with perfect performance in discrimination ability and clinical net benefit. The application of the model may help urologists to choose proper treatment and monitoring.
我们旨在建立并验证一种用于预测上尿路尿路上皮癌(UTUC)根治性肾输尿管切除术(RNU)后尿外复发(EUR)的列线图。
回顾性研究了来自2个医疗中心的521例RNU术后UTUC患者的数据,并将其用作训练队列(n = 301)和外部验证队列(n = 220)。我们使用最小绝对收缩和选择算子(LASSO)来选择多变量Cox回归的变量,并将独立危险因素纳入预测无EUR生存(EURFS)的列线图模型。使用多个参数来验证列线图,包括一致性指数(C指数)、校准图、时间依赖性受试者操作特征曲线(ROC)和决策曲线分析(DCA)。根据列线图计算的总分将患者分为三个风险组。通过Kaplan-Meier分析分析每组中EURFS的差异。
通过LASSO回归筛选出4个变量。膀胱癌病史、Ki-67、淋巴管浸润(LVI)和病理T分期被证明是EUR的独立预测因素。训练队列和验证队列中模型的C指数分别为0.793和0.793。与基于分类病理T分期的预测相比,5年EUR的DCA曲线表现更好。分层为低、中、高风险组的患者5年EURFS率分别为92.2%、63.8%和36.2%。
我们的研究提供了一种新的列线图,用于预测接受RNU的UTUC患者发生EUR的概率,在鉴别能力和临床净效益方面表现优异。该模型的应用可能有助于泌尿外科医生选择合适的治疗和监测方法。